Global Oncology Nutrition Market Size study, by Cancer (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood, Others) and by Regional Forecasts 2018-2025

September 2018 | 120 pages | ID: G1D7E15EA9BEN
Bizwit Research & Consulting LLP

Abstracts

Global Oncology Nutrition Market to reach USD 2.7 billion by 2025.

Global Oncology Nutrition Market valued approximately USD 1.23 billion in 2016 is anticipated to grow with a healthy growth rate of more than 9.2% over the forecast period 2018-2025. Increasing number of cancer patients, growing nutritional feeding in the homecare sector and the rising number of patients having treatment for malnutrition are driving the growth in the Global Oncology Nutrition Market. However, the complications involved with tube feeding and limited reparation are the main constraints in the market growth. Cancer is a term for diseases involving growth in the abnormal cell without control that can invade in other parts of the body. These cells are called tumor cells. Oncology is a branch of medicine, which involves dealing with the diagnosis, prevention, and treatment of tumor or cancer. The process of providing necessary food to the cancer patients meanwhile or after the treatment is called oncology nutrition. Proper nutrition is essential for a cancer patient who is undergoing the treatment. Such nutrition helps the patient in recovering health by providing strength and endurance against sickness after the treatment. The nutrition diet of a cancer patient includes dairy products, fruits, grain, vegetables, cereal products, bread, tofu, eggs, fish, poultry, meat and many more. Furthermore, food with high calorie and fat prevents weight loss at the time of the treatment of cancer patients. Proper nutrition helps in fast recovery of the patient by providing more energy and also manages the side effects of the cancer treatment which results in improving patient’s quality of life. Additionally, it helps in curing wounds after the treatments like chemotherapy or any other treatments.

The regional analysis of Global Oncology Nutrition Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cancer:

• Head and Neck Cancer
• Stomach and Gastrointestinal Cancers
• Liver Cancer
• Pancreatic Cancer
• Esophageal Cancer
• Lung Cancer
• Breast Cancer
• Blood Cancer
• Other Cancers

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

• Historical year – 2015, 2016
• Base year – 2017
• Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Danone, Nestle., B. Braun Melsungen AG, Abbott Laboratories, Fresenius Kabi AG, Mead Johnson & Company, LLC., Meiji Holdings Co. Ltd., Hormel Foods Corporation, Global Health Products, Inc., Victus and so on. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Oncology Nutrition Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL ONCOLOGY NUTRITION MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL ONCOLOGY NUTRITION MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL ONCOLOGY NUTRITION MARKET, BY CANCER

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Oncology Nutrition Market, Sub Segment Analysis
  5.3.1. Head and Neck Cancer
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Stomach and Gastrointestinal Cancers
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.3. Liver Cancer
    5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.4. Pancreatic Cancer
    5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.5. Esophageal Cancer
    5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.6. Lung Cancer
    5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.7. Breast Cancer
    5.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.8. Blood Cancer
    5.3.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.9. Other Cancers
    5.3.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL ONCOLOGY NUTRITION MARKET, BY REGIONAL ANALYSIS

6.1. Oncology Nutrition Market, Regional Market Snapshot (2015-2025)
6.2. North America Oncology Nutrition Market Snapshot
  6.2.1. U.S.
    6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.2.1.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.2.2. Canada
    6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.2.2.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3. Europe Oncology Nutrition Market Snapshot
  6.3.1. U.K.
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Germany
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.3. France
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.4. Rest of Europe
    6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.4.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4. Asia Oncology Nutrition Market Snapshot
  6.4.1. China
    6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.1.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.2. India
    6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.2.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.3. Japan
    6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.3.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.4. Rest of Asia Pacific
    6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.4.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.5. Latin America Oncology Nutrition Market Snapshot
  6.5.1. Brazil
    6.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.5.1.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.5.2. Mexico
    6.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.5.2.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.6. Rest of The World
  6.6.1. South America
    6.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.6.1.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.6.2. Middle East and Africa
    6.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.6.2.2. Cancer breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. COMPETITIVE INTELLIGENCE

7.1. Company Market Share (Subject to Data Availability)
7.2. Top Market Strategies
7.3. Company Profiles
  7.3.1. Danone
    7.3.1.1. Overview
    7.3.1.2. Financial (Subject to Data Availability)
    7.3.1.3. Product Summary
    7.3.1.4. Recent Developments
  7.3.2. Nestle.
  7.3.3. B. Braun Melsungen AG
  7.3.4. Abbott Laboratories
  7.3.5. Fresenius Kabi AG
  7.3.6. Mead Johnson & Company, LLC.
  7.3.7. Meiji Holdings Co. Ltd.
  7.3.8. Hormel Foods Corporation
  7.3.9. Global Health Products, Inc.
  7.3.10. Victus